Document Detail


Two pyridinium metabolites of haloperidol are present in the brain of patients at post-mortem.
MedLine Citation:
PMID:  9042387     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We have shown in patients taking the antipsychotic drug haloperidol (HP) that two pyridinium metabolites (HPP+ and RHPP+) are present in blood and urine in nM concentrations. These metabolites are structurally analogous to MPP+, the neurotoxic metabolite of the well-known parkinsonian-producing protoxin, MPTP. In this study we measured the concentrations of HPP+ and RHPP+ in seven regions of the brain (putamen, substantia nigra, globus pallidus, caudate, hippocampus, cerebellum and occipital cortex) obtained at post-mortem from three patients who were taking HP before death. Blood, urine, and bile from one patient were analysed as well. HPP+ was present in all regions (except for substantia nigra in one patient and globus pallidus in another); the amount/g ranged from 1.6-8.3 pMol but there was no preferential sequestration of the metabolite in dopaminergic regions. Similarly, RHPP+ was present relatively uniformly in all regions; the amount/g ranged from 1.1-7.6 pMol. The concentrations of HPP+ and RHPP+ in one patient were 24 and 13 nM in blood, 660 and 230 nM in urine, and 13.0 and 1.4 microM in bile, respectively. The presence of these pyridinums in brain adds another important piece of information to the case that, at least for HP, metabolite-induced neurotoxicity could contribute to the extrapyramidal side-effects in patients receiving long-term therapy.
Authors:
D W Eyles; K M Avent; T J Stedman; S M Pond
Related Documents :
738067 - Depletion of awareness and double-simultaneous stimulation in split-brain man.
6655477 - Tardive dyskinesia: clinical correlation with computed tomography in patients aged less...
14963747 - The origin of brain metastases in patients with an undiagnosed primary tumour.
2263307 - Haemodynamic changes in patients with subarachnoid haemorrhage assessed by tc99m labele...
15795697 - A comparative study of the role of erythropoietin in the pathogenesis of deficient eryt...
8793587 - Torsades de pointes induced by transesophageal atrial stimulation after administration ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Life sciences     Volume:  60     ISSN:  0024-3205     ISO Abbreviation:  Life Sci.     Publication Date:  1997  
Date Detail:
Created Date:  1997-03-25     Completed Date:  1997-03-25     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0375521     Medline TA:  Life Sci     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  529-34     Citation Subset:  IM    
Affiliation:
Department of Medicine, University of Queensland, Princess Alexandra Hospital, Brisbane, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antipsychotic Agents / metabolism*
Autopsy
Bile / metabolism
Brain / metabolism*
Chromatography, High Pressure Liquid
Haloperidol / analogs & derivatives*,  blood,  metabolism*,  urine
Humans
Pyridinium Compounds / blood,  metabolism*,  urine
Reference Standards
Tissue Distribution
Chemical
Reg. No./Substance:
0/4-(4-chlorophenyl)-1-(4-(4-fluoro-phenyl))-4-hydroxybutylpyridinium; 0/Antipsychotic Agents; 0/Pyridinium Compounds; 125785-69-5/N-(4'-fluorobutyrophenone)-4-(4-chlorophenyl)pyridinium; 52-86-8/Haloperidol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Increased microbicidal activity of human monoblastoid cells upon long-term exposure to dideoxycytidi...
Next Document:  Interaction of ebeinone, an alkaloid from Fritillaria imperialis, at two muscarinic acetylcholine re...